Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond.
Bladder neoplasms
Diet
Dietary patterns
Epidemiology
Immunotherapy
Micronutrients
Risk factors
Treatment outcomes
Journal
Oncology and therapy
ISSN: 2366-1089
Titre abrégé: Oncol Ther
Pays: New Zealand
ID NLM: 101677510
Informations de publication
Date de publication:
28 Feb 2024
28 Feb 2024
Historique:
received:
09
01
2024
accepted:
02
02
2024
medline:
28
2
2024
pubmed:
28
2
2024
entrez:
28
2
2024
Statut:
aheadofprint
Résumé
Bladder cancer is considered a global health concern characterized by significant morbidity and mortality rates. The complex relationship between diet and bladder cancer is examined, with a specific focus on the role of diet in risk, outcomes, and treatment efficacy. Attention is drawn to the burgeoning field of immunotherapy in bladder cancer treatment, and the possible influence of diet on its outcomes is explored. While evidence remains limited, prior studies in other cancer types have suggested a potential connection between diet and immunotherapy response. To address this knowledge gap, the ongoing BLOSSOM study is presented, which aims to investigate the link between dietary factors, lifestyle, and the effectiveness of immunotherapy in patients with non-muscle-invasive bladder cancer. Ongoing efforts to decipher the intricate relationship between diet and bladder cancer care are highlighted, emphasizing the quest to unravel the dietary puzzle for the improvement of bladder cancer management.
Identifiants
pubmed: 38416326
doi: 10.1007/s40487-024-00266-7
pii: 10.1007/s40487-024-00266-7
doi:
Types de publication
Editorial
Langues
eng
Informations de copyright
© 2024. The Author(s).
Références
Cespedes EM, Hu FB. Dietary patterns: from nutritional epidemiologic analysis to national guidelines. Am J Clin Nutr. 2015;101:899–900. https://doi.org/10.3945/ajcn.115.110213 .
doi: 10.3945/ajcn.115.110213
pubmed: 25832336
pmcid: 4409695
Steinmaus CM, Nuñez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol. 2000;151:693–702. https://doi.org/10.1093/oxfordjournals.aje.a010264 .
doi: 10.1093/oxfordjournals.aje.a010264
pubmed: 10752797
Jubber I, Ong S, Bukavina L, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84:176–90. https://doi.org/10.1016/j.eururo.2023.03.029 .
doi: 10.1016/j.eururo.2023.03.029
pubmed: 37198015
Brinkman MT, Karagas MR, Zens MS, Schned A, Reulen RC, Zeegers MP. Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control. 2010;21:609–19. https://doi.org/10.1007/s10552-009-9490-0 .
doi: 10.1007/s10552-009-9490-0
pubmed: 20043202
Zhang X, Li H, Lv X, et al. Impact of diets on response to immune checkpoint inhibitors (ICIs) therapy against tumors. Life. 2022;12:409. https://doi.org/10.3390/life12030409 .
doi: 10.3390/life12030409
pubmed: 35330159
pmcid: 8951256
Mukherjee N, Wheeler KM, Svatek RS. Bacillus Calmette–Guérin treatment of bladder cancer: a systematic review and commentary on recent publications. Curr Opin Urol. 2019;29:181–8.
Ferro M, Crocetto F, Tataru S, et al. Predictors of efficacy of immune checkpoint inhibitors in patients with advanced urothelial carcinoma: a systematic review and meta-analysis. Clin Genitourin Cancer. 2023. https://doi.org/10.1016/j.clgc.2023.05.017 .
doi: 10.1016/j.clgc.2023.05.017
pubmed: 38281877
Barone B, Calogero A, Scafuri L, et al. Immune checkpoint inhibitors as a neoadjuvant/adjuvant treatment of muscle-invasive bladder cancer: a systematic review. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14102545 .
doi: 10.3390/cancers14102545
pubmed: 36497416
pmcid: 9397562
Al-Zalabani AH, Stewart KFJ, Wesselius A, Schols AMWJ, Zeegers MP. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol. 2016;31:811–51. https://doi.org/10.1007/s10654-016-0138-6 .
doi: 10.1007/s10654-016-0138-6
pubmed: 27000312
pmcid: 5010611
Taylor J, Gupta N, Blanck J, Loeb S. A systematic review of plant-based diets and bladder cancer: a call for further research. Soc Int Urol J. 2022;3:240–4. https://doi.org/10.48083/GBMA2534 .
doi: 10.48083/GBMA2534
Dianatinasab M, Forozani E, Akbari A, et al. Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis. BMC Public Health. 2022;22:73. https://doi.org/10.1186/s12889-022-12516-2 .
doi: 10.1186/s12889-022-12516-2
pubmed: 35016647
pmcid: 8753903
Dai Z-W, Cai K-D, Li F-R, Wu X-B, Chen G-C. Association between coffee consumption and risk of bladder cancer in a meta-analysis of 16 prospective studies. Nutr Metab (Lond). 2019;16:66. https://doi.org/10.1186/s12986-019-0390-3 .
doi: 10.1186/s12986-019-0390-3
pubmed: 31528185
Fan FS. Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine. Front Oncol. 2022;12:1029491. https://doi.org/10.3389/fonc.2022.1029491 .
doi: 10.3389/fonc.2022.1029491
pubmed: 36330474
pmcid: 9623052
Alam M, Ashraf GM, Sheikh K, et al. Potential therapeutic implications of caffeic acid in cancer signaling: past, present, and future. Front Pharmacol. 2022;13: 845871. https://doi.org/10.3389/fphar.2022.845871 .
doi: 10.3389/fphar.2022.845871
pubmed: 35355732
pmcid: 8959753
Xenou D, Tzelves L, Terpos E, Stamatelopoulos K, Sergentanis TN, Psaltopoulou T. Consumption of fruits, vegetables and bladder cancer risk: a systematic review and meta-analysis of prospective cohort studies. Nutr Cancer. 2022;74:2003–16. https://doi.org/10.1080/01635581.2021.1985146 .
doi: 10.1080/01635581.2021.1985146
pubmed: 34726552
Golčić M, Simetić L, Herceg D, et al. Analysis of the gut microbiome and dietary habits in metastatic melanoma patients with a complete and sustained response to immunotherapy. Cancers (Basel). 2023;15:3052. https://doi.org/10.3390/cancers15113052 .
doi: 10.3390/cancers15113052
pubmed: 37297014
Bolte LA, Lee KA, Björk JR, et al. Association of a Mediterranean diet with outcomes for patients treated with immune checkpoint blockade for advanced melanoma. JAMA Oncol. 2023;9:705–9. https://doi.org/10.1001/jamaoncol.2022.7753 .
doi: 10.1001/jamaoncol.2022.7753
pubmed: 36795408
pmcid: 9936383
Mirto BF, Scafuri L, Sicignano E, et al. Nature’s hidden gem: quercitrin’s promising role in preventing prostate and bladder cancer. Future Sci OA. 2023;9:FSO67. https://doi.org/10.2144/fsoa-2023-0041 .
doi: 10.2144/fsoa-2023-0041
Crocetto F, di Zazzo E, Buonerba C, et al. Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of the literature. Nutrients. 2021. https://doi.org/10.3390/nu13113750 .
doi: 10.3390/nu13113750
pubmed: 34836005
pmcid: 8621729
Buonerba C, De Placido P, Bruzzese D, et al. Isoquercetin as an adjunct therapy in patients with kidney cancer receiving first-line sunitinib (QUASAR): results of a phase I trial. Front Pharmacol. 2018. https://doi.org/10.3389/fphar.2018.00189 .
doi: 10.3389/fphar.2018.00189
pubmed: 29615901
pmcid: 5864863